6 results match your criteria: "COVID-19 Vaccine Safety Research Center[Affiliation]"

The emergence of the omicron variant and its sub-lineages has necessitated vaccine updates for coronavirus disease 2019. In September 2023, the U.S.

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 vaccines demonstrate effectiveness but can cause adverse events (AEs), highlighting the need for ongoing monitoring to ensure safety and public health management.
  • A study analyzed data from over 42 million vaccinated individuals in South Korea from February 2021 to January 2023, focusing on the frequency and severity of AEs related to vaccine dosages.
  • Findings revealed that headaches, muscle pain, and fever were common AEs, with women reporting them more often than men, and middle-aged individuals (50-64 years) showing the highest rates compared to other age groups and socio-economic statuses.
View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 Vaccine Safety Research Center (CoVaSC) was created in South Korea to investigate potential links between COVID-19 vaccines and adverse events during the pandemic, with backing from health authorities.
  • Traditional methods for determining causality in medical events faced limitations, prompting an update of a causality assessment framework by the National Academies of Sciences, Engineering, and Medicine (NASEM) in 2024, which uses a weight-of-evidence approach.
  • This updated framework evaluates both epidemiological evidence from population studies and mechanistic evidence from biological studies, allowing for a comprehensive conclusion on causality, categorized from "convincingly supports" to "inadequate to accept or reject."
View Article and Find Full Text PDF

This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 vaccine in the Republic of Korea. Systematic electronic searches of Ovid-Medline, Embase, CENTRAL, and KoreaMed databases were conducted on March 22, 2023.

View Article and Find Full Text PDF
Article Synopsis
  • - The COVID-19 Vaccine Safety Research Committee (CoVaSC) was formed in November 2021 to gather independent data on adverse events related to COVID-19 vaccinations, led by Korea's National Academy of Medicine and requested by the Korea Disease Control and Prevention Agency.
  • - In September 2022, the COVID-19 Vaccine Safety Research Center was established, restructuring CoVaSC into four specialized departments focused on research, communication, and policy regarding vaccine safety.
  • - The center has conducted comprehensive studies on 27 adverse events, involving collaboration between experts and regular updates to the public, while planning to enhance its research efforts and maintain transparency in its findings.
View Article and Find Full Text PDF

With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication.

View Article and Find Full Text PDF